NAFLD is a fatty infiltration of the liver and the first pathological step for nonalcoholic steatohepatitis (NASH), a. Below are some of the ICD-10-CM Diagnosis codes that could potentially be assigned based on provider documentation. Evidence of steatohepatitis included a steatohepatitis NLP affirmation. It’s a rare and more serious form of nonalcoholic fatty liver. Health Care Costs are Double for Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Compensated Cirrhosis (CC) who Progress to End-Stage Liver Disease (ESLD). Not Valid for Submission. Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE. 571. Zoli M, Melchionda N: Metformin in non-alcoholic steatohepatitis. ICD-10-CM Code for Fatty (change of) liver, not elsewhere classified K76. Epidemiologic studies of alcoholic hepatitis (AH) have been hindered by the lack of a validated International Classification of Disease (ICD) coding algorithm for use with administrative data. [1] There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic. NASH is diagnosed when examination of the tissue with a microscope. Equivalent. K76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 69 became effective on October 1, 2023. 89 Other specified inflammatory liver diseases; K75. While also a condition of fat in the liver, those with nonalcoholic steatohepatitis have liver inflammation and, usually, liver cell damage as. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in shrsp5/dmcr rat model. 1Alcoholic hepatitis. Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. Diagnoses and procedure codes appear in eTables 1-5 in Supplement 2. Other chronic nonalcoholic liver disease. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. Liver biopsy and histology is the gold standard for diagnosis, and is performed for patients at higher risk of fibrosis or steatohepatitis. 02 may differ. NAFLD encompasses a spectrum of severity ranging from typically non-progressive simple steatosis or nonalcoholic fatty liver (NAFL) to. A silent disease with no symptoms or mild symptoms such as tiredness and fatigue in early stages. Cryptogenic cirrhosis accounts for nearly 5% to 30% of cases of cirrhosis and nearly 10% of liver transplants. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NFS, NAFLD fibrosis score, NLP, natural language processing. 0) and NASH (K75. K76. 81), whereas the ICD-9 codes are more ambiguous and could represent either NAFL or NASH. K74. 500 results found. 2024 ICD-10-CM Range K00-K95. 08. ICD coding. 00 - K74. Nonalcoholic steatohepatitis (NASH) - instead, use code K75. The non-alcoholic steatohepatitis (NASH) market size is projected to reach $24. A, For those with improvement in diagnosis, fibrosis stage is shown for those with diagnosis change from nonalcoholic steatohepatitis (NASH) to nonalcoholic fatty liver (NAFL) (n = 61), borderline to NAFL. 81. Cirrhosis develops in 21% to 28 % of NASH patients compared to only 3% of patients with NAFL []. Diagnoses and procedure codes appear in eTables 1-5 in Supplement 2. K75. To prevent possible data-leakage, we only considered patient medical codes at least a month before the diagnosis of their respective ailment and manually deleted all medical codes corresponding to the diagnosis of NAFLD, NASH or liver biopsy test. doi: 10. -) Hepatic ascites and chronic active hepatitis due to toxic liver disease. Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic; Applies To. INTRODUCTION. K75. (2022) How To Code Chronic Constipation ICD 10 – List With Codes & Guidelines. 75 (P < 0. 1 About 35% of patients with NASH develop progressive liver fibrosis. Within the wide spectrum of NAFLD, nonalcoholic steatohepatitis (NASH) is a progressive form of disease that often develops into liver cirrhosis and increases the risk of hepatocellular carcinoma (HCC). Type 2 Excludes. -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis. Pasien yang kelebihan berat badan perlu menurunkan berat badan. 9, K75. 9 [convert to ICD-9-CM] Non-alcoholic fatty liver disease (NAFLD) consists of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). 9 is applicable to adult patients aged 15 - 124 years inclusive. This is the American ICD-10-CM version of K71. codes (together called medical codes) from the EMR tables. 6 - other international versions of ICD-10 K74. 65%: Singal et al. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. ICD-10-CM Diagnosis Code K75. Test: 550960. It is a liver disease from the family of NAFLD (non-alcoholic fatty liver. This applies to chronic yellow atrophy (liver) and fatty liver without mention of alcohol. 81. Code Classification: Diseases of the digestive system (K00–K93) Diseases of liver (K70-K77). 0. Most patients with moderate disease are undernourished and present with fatigue, fever, jaundice, right upper quadrant pain, tender hepatomegaly, and sometimes a hepatic bruit. Nonalcoholic steatohepatitis (NASH) - instead, use code K75. NAFLD is a spectrum of disease ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and it occurs when the accumulation of fatty acid content exceeds 5% of liver weight. 81 is a billable ICD code used to specify a diagnosis of nonalcoholic steatohepatitis (NASH). ICD-9-CM 571. Other inflammatory liver diseases. Clinical background. The Hospital Discharge Abstract Database (DAD) was used to. 0 may differ. ICD-10 codes for esophageal varices with bleeding. (ICD-9) codes. 9. A NAS of 5 or higher correlates with a diagnosis of NASH whereas a NAS of less than 3 is not consistent with this diagnosis. (1,2). ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. 0 -) There has been an increased interest in non-alcoholic fatty liver disease (NAFLD), and its advanced stage, non-alcoholic steatohepatitis (NASH) because of their increasing impact on global health . K75. 01-E. MASLD encompasses patients who have hepatic steatosis and have at least one of five cardiometabolic risk. Obesity may be represented by ICD-10-AM codes under the E66 code block or by the chronic conditionICD-10-CM Diagnosis Code K75. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world, with an estimated prevalence of approximately 25% [1, 2]. ICD-9-CM 571. ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. A swollen belly ( ascites) Bruising and bleeding easily. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. 11 - other international versions of ICD-10 K71. The presence of cirrhosis was determined based on results of imaging or ICD-9 or 10 codes. 8 should only be used for claims with a date of service on or before September 30, 2015. 02: Hepatic fibrosis:. 4% of. Diagnosis Code for Reimbursement Claim: ICD-9-CM 571. Nonalcoholic fatty liver disease (NAFLD) is today the most common cause of chronic liver disease and second only to viral hepatitis as a cause of liver transplantation in the U. K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. Evidence of fibrosis included either an ICD-10 diagnosis code, a fibrosis NLP diseases (non-alcoholic steatohepatitis)’ and K76. (OSA) and non-alcoholic steatohepatitis (NASH) from a large national inpatient sample database. Ask a Question. 2298. Histological findings indicative of non-alcoholic steatohepatitis (NASH) (i. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/ or non-alcoholic steatohepatitis. in; a Local Coverage Determination (LCD) policy or Article ID; or a CPT/HCPCS procedure/billing code or an ICD-10-CM diagnosis code. 1 contain annotation back-references that may be applicable to K70. DRGs; HCCs; ICD-11; SNOMED CT; ICD-9-CM;. The E-DII. ICD-10-CM Coding Rules. K70. 6 ‘Other and unspecified cirrhosis of liver’. The 2024 edition of ICD-10-CM K70. Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD) affects ~70% of patients with type 2 diabetes (T2D), with ~20% showing signs of advanced liver fibrosis. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 0; Other cirrhosis of liver – K74. This article will outline the causes, symptoms, diagnosis, treatment and the ICD 10 CM code for NASH. Medical history Your. 571. 401-421-3185. ; The 2024 edition of ICD-10-CM K74. 81 K75. If your doctor feels that further confirmation is needed to make a definitive diagnosis of NASH, a liver biopsy may be ordered. Acknowledgements. K70. NASH/NAFLD is the most common chronic liver disease. Choose Language. 8. The reasons for lowlevel awareness are the relatively recent coining of the term “NASH” in 1980, the requirement of a liver biopsy for definitive diagnosis, the relatively indolent nature of the disease in most patients, and the lack of a consensus regarding histological. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ and K76. The 2022 edition of ICD-10-CM K75. This is the American ICD-10-CM version of K74. Bethesda, MD 20892–3570 . A recent analysis of studies involving more than 8. 0 [convert to ICD-9-CM]Metabolic dysfunction-associated steatohepatitis (non-alcohol related steatohepatitis) is a type of fatty liver disease that causes inflammation and liver damage. (NAFLD) can be daunting but watch how Shawanna met the challenge head on and is reversing her diagnosis with weight loss, healthy eating and exercise!Since the code for ICD-10 (International Classification of Diseases) does not have a single designation, today the most common encoding is K76. Bookshelf ID: NBK470243 PMID: 29262166. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. Overview Symptoms and Causes Diagnosis and Tests Management and Treatment Prevention Outlook / Prognosis. Methods: We performed a prospective study on patients with. 571. However, there is general consensus that, for those patients who do progress to cirrhosis (fibrosis stage 4), there is an. 02 Hepatic fibrosis, advanced fibrosis Hepatic fibrosis occurs when healthy liver tissue becomes scarred. Jun 09, 2023. It is found in the 2024 version of the ICD-10 Clinical. The new codes are as follows:K74. The main treatment option for steatohepatitis is lifestyle modification. The diagnosis of alcoholic hepatitis is a clinical one with supporting laboratory findings of AH. miRNA is a small non-coding RNA, comprising ≤ 25 nucleotides. 3. 22052/12 May 2015). Nonalcoholic steatohepatitis (NASH) Show additional info Hide additional info. Lancet Gastroenterol. Methods This prospective cohort study included 171,544 UK Biobank participants. Code Classification: Diseases of the digestive system (520–579) Other diseases of digestive system (570-579) 571 Chronic liver disease and cirrhosis. e. ICD-10-CM Diagnosis Code K70. 2024 ICD-10-CM Range K00-K95. The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL). Background. NON-BILLABLE | ICD-10 from 2011 - 2016. poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4); alcoholic liver disease (K70. Code First. 9 contain annotation back-references. The reasons for lowlevel awareness are the relatively recent coining of the term “NASH” in 1980, the requirement of a liver biopsy for definitive diagnosis, the relatively indolent nature of the disease in most patients, and the lack of a consensus regarding histological. Methods:. In NAFL, hepatic steatosis is present without evidence of significant inflammation, whereas in NASH, hepatic steatosis is associated with hepatic inflammation that may be histologically indistinguishable from alcoholic steatohepatitis [. 0 - other international versions of ICD-10 K76. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Liver biopsy is the best way to diagnose NASH and clearly shows the amount of liver damage. 0 may differ. 5 million persons from 22 countries. Davis, MD, MPH 2 ; Sonal Kumar, MD, MPH 3 Author Affiliations Article InformationNAFLD is becoming more common around the world, especially in Middle Eastern and Western nations as the number of people with obesity rises. [3] It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the. MS-DRG Mapping . (ICD-9 codes 401–405), defined as a blood pressure ≥ 130/85 mmHg, (2) diabetes mellitus (DM; ICD-9 code 250. Occasionally there may be. In the United States, about 100 million people have NAFLD. 9 million patients in 2030 (~1/3. However, codes underestimated the prevalence of NAFLD/NASH and obesity by 42. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. 0 may differ. 1097/MEG. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . 81); Nonalcoholic fatty liver disease (NAFLD) ICD-10-CM Diagnosis Code L72. You may feel tired or have pain in the upper right side of your abdomen, where your liver is. A 70-year-old patient with a history of nonalcoholic steatohepatitis (NASH) cirrhosis complicated by hepatic encephalopathy and diabetes presented to the emergency department (ED). 1% from 2021 to 2028. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ or K76. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. ICD-10-CM Diagnosis Code K75. Non-alcoholic steatohepatitis (NASH) is a serious chronic liver disorder of increasing prevalence worldwide. 81. Long Description: Other chronic nonalcoholic liver disease. 8 ICD-9 Billable. 01 Hepatic fibrosis, early fibrosis K74. Fibrosis scores included APRI, NFS, Fib-4, and. HCC Plus. See full list on my. A new category, outside pure MASLD, termed MetALD (pronunciation: Met A-L-D) was selected to describe those with MASLD who consume greater amounts of alcohol per week (140 g/week and 210 g/week for females and males respectively). Showing 1-25: ICD-10-CM Diagnosis Code K70. The prevalence of NAFLD has been increasing (25. Additionally, they identify recombinant ORM2 protein therapy as a promising strategy for reversing liver steatosis and steatohepatitis. This is the American ICD-10-CM version of K76. 2019;101:154005. Mr T, a 60-year-old man, has obesity, diabetes mellitus, and increased serum transaminase levels. 6–8 However, approximately 10–30% have the. Other Codes Used Similar Conditions. for Non-Alcoholic Steatohepatitis: The New Epidemic, Ann Surg, 256(4):624–633. Clinics for Diagnosis. 2010. Based on the ICD codes outlined in Table 1, the cohort labels were obtained as With the recent transition to ICD-10-CM with a specific diagnostic code for NAFLD, a study in England showed the incidence rate of NAFLD of 29 per 100,000 person-years with significant underestimated rates due to ICD-10 code. 9 may differ. , 2005; Diehl and Day, 2017 ). ICD-9-CM 571. ICD-10-CM Diagnosis Code K70. codes reported an incidence rate for NAFLD of 29 per 100,000 person-years. 8% of the total causes of death from chronic liver disease ( Golabi et al. NASH is characterized by steatosis accompanied by hepatocyte. Nonalcoholic fatty liver disease (NAFLD) Type 1 Excludes. 0Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver enzymes in both adults and children. Hepatitis, unspecified. NAFLD/NASH cirrhosis may also attract code K74. Code Version: 2015 ICD-9-CM. Menu. NASH has an estimated prevalence of 3% to 5% in the US general population. Liver biopsy is an invasive procedure that carries a 0. 1. 81 NASH code and liver biopsy); ICD-10 NASH (patients with an ICD-10 K75. Type 2 Excludes. Showing 1-25: ICD-10-CM Diagnosis Code K70. 7. In. The 2024 edition of ICD-10-CM K75 became effective on October 1, 2023. To date, there is no simple noninvasive test for diagnosing NASH. Nonalcoholic fatty liver; Non-alcoholic fatty liver; Nonalcoholic steatohepatitis; Portal fibrosis without cirrhosis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Clinical Information. Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. Overall concordance between clinical documentation and 'grouped alcohol' codes (κ 0. DRG Group #441-443 - Disorders of liver except malig, cirr, alc hepa with MCC. Diagnosis and Management of Nonalcoholic Fatty Liver Disease Peggy B. ContentsK75. To assess stage of. 650-498-7878. 4. 31 [convert to ICD-9-CM] Alcoholic cirrhosis of liver with ascites. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Nonalcoholic steatohepatitis (NASH) is the inflammatory form of nonalcoholic fatty liver disease (NAFLD). 8 A meta-analysis published in 2016 showed that the pooled regional incidence rate estimates for Israel and Asia were 28. Metabolic dysfunction–associated steatotic liver disease ( MASLD) is the name adopted in 2023 for the condition previously known as non-alcoholic fatty liver disease ( NAFLD ). ; This is the American ICD-10-CM version of. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. Medical history. NAFL is defined as the presence of 5% HS without evidence. Non-alcoholic fatty liver disease (NAFLD) is a range of liver disease characterized by the occurrence of steatosis in greater than 5% of hepatocytes of people who drink tiny or no alcohol. 1), those with viral hepatitis (070, 573. Nonalcoholic Steatohepatitis (NASH): Treatment Test: 550960. It is the most common liver disease in the United States. 0. Cochrane Database Syst. 00 became effective on October 1, 2023. Nonalcoholic steatohepatitis (NASH) - instead, use code K75. For exclusion criteria, individuals with other causes of hepatitis (ICD codes ICD-9-CM 303. 81; Fatty liver, not elsewhere classified – K76. It is currently the most common. The following code (s) above K74. It is usually done using a needle through the abdominal wall. 6 ‘Other and unspecified cirrhosis of liver’. 0-1. Our large population database results emphasize that there is a significant association between OSA and NASH. The tissue sample is looked at in a lab for signs of inflammation and scarring. Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic; Applies To. 6 became effective on October 1, 2023. Alcoholic steatohepatitis and non-alcoholic steatohepatitis: Definitions, clinical signs and histological features. 0. Patients are diagnosed with NAFLD when secondary causes are not apparent (e. 0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. Nonalcoholic steatohepatitis (NASH), the severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma (HCC). Nonalcoholic fatty liver disease (NAFLD) is a wide-spectrum disease entity from simple hepatic steatosis to nonalcoholic steatohepatitis. Our large population database results emphasize that there is a significant association between OSA and NASH. 0) from the Karolinska University Hospital between 1 January 2015 and 3 November 2021 were randomly selected. Learn what factors determine a diagnosis for NASH. , 2016; Liu et al. 0 [convert to ICD-9-CM] INTRODUCTION. The 2024 edition of ICD-10-CM K74. 9 may differ. This assay currently is not available in New York state. If you have NASH, you have inflammation and liver damage, along with fat in your liver. We identified the diagnosis of HCC in both study and control groups. We selected Medicare beneficiaries without known prior diagnosis of HF. 0 - other international versions of ICD-10 K70. 81 became effective on October 1, 2023. The following code (s) above K74. Overview. Some patients with NAFLD progress to nonalcoholic. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 31 [convert to ICD-9-CM] Alcoholic cirrhosis of liver with ascites. 0 may differ. Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver-specific and overall mortality. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as listed by WHO under the range – Diseases of the digestive system . 571. 81, K76. ICD-9-CM 571. It is imperative to distinguish simple steatosis from NASH since the latter. How is nonalcoholic steatohepatitis (NASH) treated? Treatment for NASH includes managing conditions that increase your risk for NASH or make it worse. Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is associated with metabolic syndrome and is rapidly increasing globally with the increased prevalence of obesity. ECGs or ICD-9 code: Community-based 9333 individuals without baseline AF; aged 53–75 y: Prospective cohort: 12 y: Incident AF:. Other inflammatory liver diseases. Doctors use your medical history, a physical exam, and tests to diagnose nonalcoholic fatty liver disease (NAFLD)—including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). An ache in the upper right part of your belly. 0, 571. 11 may differ. 6 became effective on October 1, 2023. This is the American ICD-10-CM version of K70. K74. Hepatic fibrosis. Excludes2: alcoholic liver disease (K70. 0 - fatty (change of) liver, not. 12978,. Nonalcoholic steatohepatitis (NASH), a more serious form of the disease, occurs when, along with the fat build up, there is inflammation and subsequent irreversible damage to the liver. This is the American ICD-10-CM version of K70. 02 - other international versions of ICD-10 K74. g. x) and insulin resistance (ICD-9 code 277. 2 to ICD-10-CM. Exp Mol Pathol. Subcohorts for analysis were created based on (1) NASH status: biopsy-confirmed NASH (patients with an ICD-10 K75. Non-alcoholic steatohepatitis (NASH), the more progressive form of NAFLD, is particularly challenging to diagnose in the absence of histology. 9 - other international versions of ICD-10 K70. Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Nonalcoholic steatohepatitis (NASH) Show additional info Hide additional info. ICD-9: 571. 81) ICD-10-CM Diagnosis Code K76. Int. A recent analysis of studies involving more than 8. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. 6 - other international versions of ICD-10 K74. (2014) USA: Adults receiving liver kidney transplant: Observational cohort study United Network of Organ Sharing (UNOS) database ICD-10-CM Codes. K74. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. 81 - Nonalcoholic steatohepatitis (NASH) The above description is abbreviated. 0From the AFP Editors. The following code (s) above K74. The code is valid during the current fiscal year for the. Nonalcoholic Steatohepatitis or simply NASH is a liver condition in which fat buildup in the liver causes inflammation and liver damage [6, 13]. 10 - other international versions of ICD-10 K70. All patients should have had an abdominal imaging study to exclude biliary obstruction and liver diseases such as hepatocellular carcinoma and liver abscess. 0) of liver fibrosis (Metavir F0. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. Legacy ICD-9-CM Codes; Indexes . 0 – other international versions of ICD-10 K76. Nonalcoholic steatohepatitis (NASH) is part of a spectrum of conditions collectively referred to as nonalcoholic fatty liver disease (NAFLD).